Whether it’s a bull or bear market, TrendingWallStreet has you covered. Take a few minutes to register with us at http://www.trendingwallstreet.com/ to get exclusive access to our free stock reports.
Baltic Trading Limited (NYSE: BALT) shares closed up 8.12 percent on Thursday with almost 2.6 million shares traded. It was a strong day for shipping stocks on Thursday. The company had no significant news otherwise. Baltic Trading Limited engages in shipping business in the dry bulk industry spot market worldwide.
Get more information on Baltic Trading Limited and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/BALT
Vapor Corp. (OTC: VPCO) shares closed down 5.71 percent on Thursday, making it more than 16 percent in losses in the last two trading days. The stock was one of the biggest percentage losers in the OTC market and traded about 1.3 million shares. Vapor Corp. designs, markets, and distributes electronic cigarettes and accessories primarily in the United States and Canada.
Get more information on Vapor Corp. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/VPCO
Keryx Biopharmaceuticals Inc. (NASDAQ: KERX) shares closed down 11.85 percent on Thursday on about 8.2 million shares traded. The stock had one of the largest percentage decreases on the NASDAQ. Adam Feuerstein of TheStreet.com stated on Twitter earlier this week: "Galenica spox confirms to me Velphoro did NOT receive NCE status, therefore $KERX can pretty much forget about getting NCE for Zerenex."
Get more information on Keryx Biopharmaceuticals Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/KERX
BioTelemetry, Inc. (NASDAQ: BEAT) shares closed down 12.40 percent on Thursday, making it more than 30 percent in losses seen in the last two trading days. The stock was one of the biggest losers on the NASDAQ and traded about 2.2 million shares. The company announced that the Centers for Medicare and Medicaid Services has published a reduction to the reimbursement for remote cardiac monitoring services effective January 1, 2014.
Get more information on BioTelemetry, Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/BEAT
Disclosure: TrendingWallStreet.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.
Leave a comment...